Target intelligence / Profile preview

Coagulation factors

Molecular classification
Enzymes (most are serine proteases), Glycoproteins (Factor V, Factor VIII), Transglutaminase (Factor XIII), Cofactors (Factor V, Factor VIII)
01

Overview

Coagulation factors are a group of proteins involved in the blood clotting process. They are traditionally numbered using Roman numerals (I through XIII, with no Factor VI) and many also have common names. These factors can be classified into three main groups: the fibrinogen group (including Factors I, V, VIII, and XIII), the prothrombin group (including Factors II, VII, IX, and X), and the contact group. Most coagulation factors are serine proteases that circulate as inactive zymogens until activated during the coagulation cascade. Exceptions include tissue factor, Factor V, Factor VIII, and Factor XIII, which are not serine proteases. Many factors (II, VII, IX, and X) are vitamin K-dependent, requiring vitamin K for post-translational modification that converts specific glutamate residues to gamma-carboxyglutamate residues, making them functionally active. The coagulation cascade is traditionally divided into intrinsic (contact activation) and extrinsic (tissue factor) pathways, both converging on a common pathway. The intrinsic pathway includes Factors XII, XI, IX, and VIII, while the extrinsic pathway involves Factor VII and tissue factor. The common pathway includes Factors X, V, II (prothrombin), and I (fibrinogen). When vascular injury occurs, subendothelial collagen and von Willebrand factor are exposed, initiating platelet adhesion and activation. This is followed by the activation of coagulation factors in a cascade-like manner, ultimately resulting in the conversion of fibrinogen to fibrin and the formation of a stable clot. Deficiencies or dysfunctions of coagulation factors can lead to bleeding disorders, such as hemophilia A (Factor VIII deficiency) and hemophilia B (Factor IX deficiency), while certain mutations like Factor V Leiden can predispose individuals to thrombosis.

Other names
Clotting factorsBlood coagulation factorsHemostatic factors
02

Mechanism of action

Proteolytic activation of downstream factors, cofactor activity in enzymatic complexes, conversion of fibrinogen to fibrin, cross-linking of fibrin polymers.

03

Biological functions

Blood coagulationHemostasisWound healingThrombus formationFibrin clot generationPlatelet activation
04

Disease associations

Bleeding disorders (hemophilia, von Willebrand disease)Thrombotic disorders (Factor V Leiden)Cardiovascular diseaseStrokeDeep vein thrombosisPulmonary embolism
05

Safety considerations

Bleeding risk with anticoagulant therapyThrombotic risk with procoagulant therapyInhibitor development with factor replacement therapyAllergic reactions to factor concentrates
06

Interacting drugs

Vitamin K antagonists (warfarin)

4 more in the full profile.

07

Biomarkers

Prothrombin time (PT)International Normalized Ratio (INR)Partial thromboplastin time (PTT)Factor activity levelsD-dimer

Beyond the preview

Go deeper on Coagulation factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call